Partners

LIONEX DIAGNOSTICS AND THERAPEUTICS

Our Partners

LIONEX is actively participating and/or coordinating a number of research projects funded by the European Union, The WHO, FIND, German Federal Ministry for Research and Education (BMBF), German Federal Ministry of Commerce (BMWi).  Research fields include diagnostics, vaccine and drug development, bladder cancer biomarkers and bladder cancer therapeutics. LIONEX is a leading manufacturer of highly purified, endotoxin free, mycobacterial antigens for research on tuberculosis and other mycobacterial diseases.

LIONEX is the licensed, exclusive manufacturer and distributor of a widely known family of endotoxin removal resin under the brand name EndoTrap®. EndoGrade®Ovalbumin is another useful product for research on vaccine development.

LIONEX cooperates with large research institutions, big pharma and large, international diagnostic companies from countries across the globe.

Only a limited list of partners is mentioned here.

 

 

Finland:

 

Mozambique:

Universidade Eduardo Mondlan 

Italy:

2B Srl

Azienda Ospedaliero Universitaria

Policlinico Paolo Giaccone Palermo

Tor Vergana

UNIVERSITA DEGLI STUDI DI FIRENZE

Universita degli Studi di Roma

Central Laboratory of Advanced Diagnosis and Biomedical Research(CLADIBIOR),
University of Palermo

 

 

If you have any questions please contact us

Lionex

© 2018 Lionex GmbH

Last update:  May 31, 2019 @ 12:43 Lionex GmbH

TÜV Rheinland